Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856056) titled 'Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH' on Sept. 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Sultan Qaboos University
Condition:
Migraine
Intervention:
Drug: Nortriptyline
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: May 2027
Target Sample Size: 90
Countries of Recruitment:
Oman
To know more, visit https://clinicaltrials.gov/study/NCT07856056
Disclaimer: Curated by HT Syndication....